Blistery, linear rash with intense itching along my upper waistline/Shingles on the trunk area on the right side; This spontaneous case was received on 02-Nov-2022 from Med Communications (reference number: EQW22-05364), reported by other healthcare care professional (retired nurse) and concerned a 68-year-old, female patient.  The Patient's concurrent conditions included hypertension, high cholesterol, herpes virus (not shingles) and antiviral type of herps. The patient's concomitant medications included Famvir (famciclovir), used for another type of herpes. The patient's historical vaccines included four doses of Moderna Covid-19 vaccine, the first dose received on 26-Mar-2021 (batch number: 018B2IA), the third dose received on 27-Oct-2021 (batch number: 021F2IA), and the fourth dose received on 13-Apr-2022 (batch number: 056M2IA), after which the patient had no adverse events reported, and the second dose received on 23-Apr-2021 (batch number: 036B2IA), after which the patient experienced a flare-up of a herpes virus.  On an unspecified date in Sep-2022 (reported as 08-Sep-2022, however 'not sure of the date de to handwriting'), the patient was vaccinated with Fluad Quadrivalent (influenza vaccine inact sag 4v; dose: 0.5ml, route of administration: intramuscular, anatomical location: not reported, and indication: not reported). The batch number reported was 346334, and expiration date: 13-Apr-2023.  On the same date, the patient vaccinated with non-company, co-suspect booster dose of Pfizer BioNTech COVID-19 vaccine (tozinameran; dose, route of administration, anatomical location: not reported) because it was being recommended for 12-year-old and older individuals, the Regulatory Authority had authorized the mix and macth of booster doses as it can be chosen which covid booster doses to receive regardless of the two original doses, she was 69-year-old, and her husband had following medical conditions included congestive heat failure (CHF), atrial fibrillation (A-Fib), ventricular tachycardia, had an implantable defibrillator, diabetes, hypertension and mild pulmonary obstructive disease, and the patient added that she felt she should keep up with all covid boosters because of her health status as well.. The batch number reported was GH702.  On 14-Sep-2022, six days after receiving Fluad Quadrivalent and co-suspect booster dose of Pfizer BioNTech COVID-19 vaccine, the patient got shingles on the trunk area on the right side. As reported, she also developed a blistery, linear rash with intense itching along her upper waistline. Initially the patient thought it was contact dermatitis but as it began to worsen she determined it was shingles.  On an unspecified date in 2022, the patient missed the timeframe for the administration of the antiviral, but she did have a hunch. The patient used Famvir, that she uses for treatment of another type of herpes - not shingles.   On 20-Oct-2022, the patient did a follow-up with a physician and the diagnosis was confirmed. The patient continued usin Famvir.  On an unspecified date in 2022 (discrepantly reported as 'by the end of September'), the patient recovered from the event. As reported, the shingles condition eventually resolved.  The reporter did not provide a causality assessment. However, the patient stated that she thought there was a connection between the two covid vaccines (Pfizer and Moderna) and it led to reactivation of the various herpes infection.  The case was assessed as non-serious.  Company comment: A 68-year-old, female patient was vaccinated with Fluad Quadrivalent and non-company, co-suspect booster dose of Pfizer BioNTech COVID-19 vaccine. Six days after vaccination, the patient experienced shingles on the trunk area on the right side. As reported, she also developed a blistery, linear rash with intense itching along her upper waistline. Initially the patient thought it was contact dermatitis but as it began to worsen, she determined it was shingles. The patient did a follow-up with a physician and the diagnosis was confirmed. Causal role of the suspect vaccine is assessed as not related, due to biological implausibility.; Sender's Comments: A 68-year-old, female patient was vaccinated with Fluad Quadrivalent and non-company, co-suspect booster dose of Pfizer BioNTech COVID-19 vaccine. Six days after vaccination, the patient experienced shingles on the trunk area on the right side. As reported, she also developed a blistery, linear rash with intense itching along her upper waistline. Initially the patient thought it was contact dermatitis but as it began to worsen, she determined it was shingles. The patient did a follow-up with a physician and the diagnosis was confirmed. Causal role of the suspect vaccine is assessed as not related, due to biological implausibility.